O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+9.02%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.37M
AUM Growth
+$5.37M
(-2.2%)
Cap. Flow
-$267K
Cap. Flow
% of AUM
-4.97%
Top 10 Holdings %
Top 10 Hldgs %
30.7%
Holding
153
New
13
Increased
31
Reduced
32
Closed
21
Top Buys
| 1 |
THRD
Third Harmonic Bio
THRD
|
$110K |
| 2 |
Sarepta Therapeutics
SRPT
|
$99.3K |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$50.1K |
| 4 |
Thermo Fisher Scientific
TMO
|
$45K |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
$33.6K |
Top Sells
Sector Composition
| 1 | Healthcare | 98.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VECT
51
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $38.8K | 0.72% |
6,473,561
| – | – |
|
52
Janux Therapeutics
JANX
$1.39B
| $38.4K | 0.71% |
2,836,386
| – | – |
|
53
Ionis Pharmaceuticals
IONS
$9.65B
| $34K | 0.63% |
768,900
+315,500
| +70% | +$14K |
|
54
Tenet Healthcare
THC
$16.3B
| $33.2K | 0.62% |
643,300
-13,000
| -2% | -$671 |
|
55
scPharmaceuticals
SCPH
$296M
| $31.3K | 0.58% |
4,797,148
| – | – |
|
56
Travere Therapeutics
TVTX
$1.71B
| $30.9K | 0.57% |
1,253,130
+480,930
| +62% | +$11.9K |
|
57
RAPT Therapeutics
RAPT
$192M
| $30.1K | 0.56% |
1,251,070
+384,674
| +44% | +$9.26K |
|
58
uniQure
QURE
$945M
| $30K | 0.56% |
1,597,000
+722,151
| +83% | +$13.5K |
|
|
ALPN
59
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $29.4K | 0.55% |
4,081,592
| – | – |
|
60
ALX Oncology
ALXO
$54.1M
| $27.5K | 0.51% |
2,871,000
+684,731
| +31% | +$6.55K |
|
|
BHVN
61
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $25.8K | 0.48% |
170,769
-548,265
| -76% | -$82.9K |
|
62
TELA Bio
TELA
$65M
| $25.8K | 0.48% |
3,027,542
| – | – |
|
|
GRCL
63
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $25.4K | 0.47% |
7,884,870
| – | – |
|
64
89bio
ETNB
$1.36B
| $21.2K | 0.39% |
3,658,869
| – | – |
|
65
Iovance Biotherapeutics
IOVA
$800M
| $19.2K | 0.36% |
2,007,458
-790,983
| -28% | -$7.58K |
|
66
GH Research
GHRS
$864M
| $18.8K | 0.35% |
1,622,060
| – | – |
|
67
MeiraGTx Holdings
MGTX
$590M
| $17.7K | 0.33% |
2,108,143
-393,475
| -16% | -$3.31K |
|
68
Vaxcyte
PCVX
$4.12B
| $17.2K | 0.32% |
717,900
-795,759
| -53% | -$19.1K |
|
|
DBTX
69
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $17.1K | 0.32% |
4,945,192
| – | – |
|
70
Invivyd
IVVD
$211M
| $16.5K | 0.31% |
5,270,400
+214,400
| +4% | +$671 |
|
71
Kezar Life Sciences
KZR
$28.6M
| $15.3K | 0.28% |
1,771,700
+351,800
| +25% | +$3.03K |
|
|
TSVT
72
DELISTED
2seventy bio
TSVT
| $15.2K | 0.28% |
+1,041,300
| New | +$15.2K |
|
73
KalVista Pharmaceuticals
KALV
$725M
| $15.1K | 0.28% |
1,042,000
+856,600
| +462% | +$12.4K |
|
74
Neuropace
NPCE
$305M
| $15K | 0.28% |
4,012,281
| – | – |
|
75
Verastem
VSTM
$561M
| $14.6K | 0.27% |
+17,200,000
| New | +$14.6K |
|